Semaglutide

Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1 (GLP-1) investigated in research for its role in metabolic regulation. It is studied for its interaction with GLP-1 receptor pathways (involved in glucose balance and appetite signalling) and for its potential influence on glycaemic control, energy intake, and body weight regulation in experimental models.